IP Library Granted Patent US 11,859,244
Granted Patent B2
US 11,859,244 · App. 18/185,786 · Granted Jan 2, 2024

Amplification oligonucleotides

Inventors: Ryan Shultzaberger (San Diego, CA); Allen Lipson (San Diego, CA); Daan Witters (San Diego, CA)
Assignee: Singular Genomics Systems, Inc.
C12Q1/6855C12Q1/6874C12Q1/6876
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,859,244
App. No.
18/185,786
Granted
Jan 2, 2024
Kind
B2
Abstract

Disclosed herein, inter alia, are polynucleotides, supports, kits, and methods of use thereof for amplifying, immobilizing, and sequencing polynucleotides.

Claims (30)

1. A kit comprising

a first oligonucleotide comprising a first sequencing primer sequence and a second sequencing primer binding sequence;

a second oligonucleotide comprising from 5′ to 3′, a first platform primer sequence and a sequence complementary to the first sequencing primer sequence;

a third oligonucleotide comprising from 5′ to 3′, a second platform primer sequence and a sequence complementary to the second sequencing primer binding sequence;

wherein said first platform primer sequence comprises SEQ ID NO:92; and

said second platform primer sequence comprises SEQ ID NO:89.

2. The kit of claim 1 , wherein the first sequencing primer sequence is SEQ ID NO:152.

3. The kit of claim 2 , wherein the second sequencing primer binding sequence is SEQ ID NO:178.

4. The kit of claim 1 , further comprising a solid support.

5. The kit of claim 4 , wherein said solid support is a flow cell, particle, chip, slide, multi-well container, or unpatterned solid support.

6. The kit of claim 4 , wherein said solid support is a multi-well container.

7. The kit of claim 4 , wherein said solid support further comprises two or more wells, wherein each well comprises a first plurality of immobilized oligonucleotides, wherein each oligonucleotide of the first plurality comprises the first platform primer sequence, and a second plurality of immobilized oligonucleotides, wherein each oligonucleotide of the second plurality comprises the second platform primer sequence.

8. The kit of claim 7 , wherein said solid support comprises about 0.2 wells to about 4.0 wells per μm 2 .

9. The kit of claim 7 , wherein each of the wells is separated from each of the other wells by about 0.2 μm to about 2.0 μm.

10. The kit of claim 1 , further comprising a sequencing polymerase, and one or more amplification polymerases.

11. The kit of claim 10 , further comprising a plurality of native deoxynucleotides (dNTPs) and a plurality of modified dNTPs.

12. The kit of claim 11 , wherein said plurality of modified dNTPs comprises a reversible terminator moiety.

13. The kit of claim 1 , wherein said second oligonucleotide, said third oligonucleotide, or both said second and third oligonucleotides further comprise an index sequence.

14. The kit of claim 13 , wherein said index sequence comprises between 8 to 12 nucleotides.

15. The kit of claim 1 , further comprising a polynucleotide adapter, said polynucleotide adapter comprising a first strand comprising a first binding sequence and a first tail sequence; and a second strand comprising a second binding sequence and a second tail sequence, wherein at least a portion of the first binding sequence is hybridized to a portion of the second binding sequence; wherein the first tail sequence comprises SEQ ID NO:5, SEQ ID NO:9, SEQ ID NO:85, SEQ ID NO:92, SEQ ID NO:90, SEQ ID NO:88, SEQ ID NO:117, SEQ ID NO:119, SEQ ID NO:121, or SEQ ID NO:123 and the second tail sequence comprises SEQ ID NO:4, SEQ ID NO:102, SEQ ID NO:104, SEQ ID NO:106, SEQ ID NO:108, SEQ ID NO:134, SEQ ID NO:136, SEQ ID NO:138, or SEQ ID NO:140, and the first binding sequence comprises SEQ ID NO:152 and the second binding sequence comprises SEQ ID NO:178.

16. The kit of claim 15 , wherein the polynucleotide adapter is a Y polynucleotide adapter.

17. The kit of claim 15 , wherein the polynucleotide adapter is a hairpin adapter.

18. The kit of claim 17 , wherein the hairpin adapter comprises a cleavable site.

19. The kit of claim 17 , wherein the first tail sequence is covalently attached to the second tail sequence.

20. A kit comprising:

a first oligonucleotide comprising from 5′ to 3′, a first platform primer sequence and a first sequencing primer sequence;

a second oligonucleotide comprising from 5′ to 3′, a second platform primer sequence and a second sequencing primer sequence;

wherein said first platform primer sequence comprises SEQ ID NO:92; and

said second platform primer sequence comprises SEQ ID NO:89.

21. The kit of claim 20 , wherein the first sequencing primer sequence is SEQ ID NO:152.

Assignments (2)
SECURITY INTEREST Recorded Mar 7, 2025
From: SINGULAR GENOMICS SYSTEMS, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 070440/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2023
From: SHULTZABERGER, RYAN; LIPSON, ALLEN; WITTERS, DAAN
To: SINGULAR GENOMICS SYSTEMS, INC
Reel/Frame 063505/0073 →
Continuity (5)
Continuation PCTUS2022075843 · Sep 1, 2022
Provisional Application 63331225 · Apr 14, 2022
Provisional Application 63245414 · Sep 17, 2021
Provisional Application 63240671 · Sep 3, 2021
Related Publication 20230287493A1 · Sep 14, 2023